Effects of a web-based decision aid to support decision-making on cervical screening by Chinese working women aged 25–44

Not Applicable

Completed

• Conditions: Cervical cancer; Cancer

• Registration Number: ISRCTN59163820
• Lead Sponsor: Health and Medical Research Fund

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-08-04
• Study Completion: 2023-09-30
• Last Update Posted: 11 March 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 158

Inclusion Criteria

Current inclusion criteria as of 28/02/2024:

1. Chinese women with a Hong Kong Identity Card
2. Aged =25 and =44 years
3. Engaged in a part-time or full-time job
3. No history of cervical cancer or total hysterectomy
4. A history of sexual activity
5. Able to read or communicate in Chinese or Cantonese
6. No history of a Pap test/HPV DNA testing in their lifetime or no Pap test/HPV DNA testing in the past 3 years
7. Willing to use and have at least one computer, tablet, or smartphone

_____

Previous inclusion criteria:

1. Chinese women with a Hong Kong Identity Card
2. Aged =25 and =44 years
3. Engaged in a part-time or full-time job
3. No history of cervical cancer or total hysterectomy
4. A history of sexual activity
5. Able to read or communicate in Chinese or Cantonese
6. No history of a Pap test/HPV DNA testing in their lifetime or no Pap test/HPV DNA testing in the past 5 years
7. Willing to use and have at least one computer, tablet, or smartphone

Exclusion Criteria

Cannot read the decision aid by themselves

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Decisional conflict measured using survey questions at baseline and 2 weeks

Secondary Outcome Measures

Name	Time	Method
1. Knowledge about cervical cancer screening measured using survey questions at baseline and 2 weeks<br>2. Risk perception measured using survey questions at baseline and 2 weeks<br>3. Clarity of values measured using survey questions at baseline and 2 weeks<br>4. Screening decision (choice predisposition and choice questions) measured using survey questions at 2 weeks<br>5. Screening uptake measured using survey questions at 3 months<br>6. Acceptability of the intervention measured using a telephone interview at 2 weeks